Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Strong Trading Volume – Should You Buy?

Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) saw strong trading volume on Tuesday. 870,298 shares traded hands during trading, an increase of 15% from the average daily volume of 755,991 shares. The stock last traded at $21.6350 and had previously closed at $22.61.

Analyst Ratings Changes

Several analysts have recently commented on the company. Weiss Ratings raised Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Citigroup reissued a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Friday, July 17th. BNP Paribas Exane downgraded Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “underperform” rating and set a $19.90 price objective for the company. in a research note on Tuesday, July 28th. Berenberg Bank set a $24.00 price objective on Fresenius Medical Care AG & Co. KGaA in a research report on Tuesday, September 29th. Finally, Sanford C. Bernstein lifted their target price on Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the company a “market perform” rating in a research note on Thursday, August 6th. Seven analysts have rated the stock with a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Reduce” and an average target price of $23.42.

Fresenius Medical Care AG & Co. KGaA Trading Down 3.7%

The business’s 50 day moving average price is $22.37 and its 200-day moving average price is $22.87. The company has a market cap of $11.69 billion, a price-to-earnings ratio of 11.27, a PEG ratio of 5.28 and a beta of 0.74. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.75 and a current ratio of 1.07.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.04. The firm had revenue of $5.55 billion for the quarter, compared to analysts’ expectations of $5.48 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.83% and a return on equity of 9.28%. On average, research analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current year.

Institutional Trading of Fresenius Medical Care AG & Co. KGaA

Hedge funds and other institutional investors have recently modified their holdings of the stock. Tidal Investments LLC raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 96.0% during the second quarter. Tidal Investments LLC now owns 99,790 shares of the company’s stock worth $2,256,000 after acquiring an additional 48,885 shares during the last quarter. Royal Bank of Canada lifted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 479.2% during the first quarter. Royal Bank of Canada now owns 216,861 shares of the company’s stock valued at $4,893,000 after acquiring an additional 179,418 shares during the period. Quantinno Capital Management LP boosted its holdings in Fresenius Medical Care AG & Co. KGaA by 15.7% in the first quarter. Quantinno Capital Management LP now owns 341,343 shares of the company’s stock valued at $7,701,000 after acquiring an additional 46,428 shares during the last quarter. Sei Investments Co. boosted its holdings in Fresenius Medical Care AG & Co. KGaA by 80.7% in the first quarter. Sei Investments Co. now owns 120,704 shares of the company’s stock valued at $2,723,000 after acquiring an additional 53,922 shares during the last quarter. Finally, Assetmark Inc. boosted its holdings in Fresenius Medical Care AG & Co. KGaA by 190.7% in the first quarter. Assetmark Inc. now owns 132,320 shares of the company’s stock valued at $2,985,000 after acquiring an additional 86,798 shares during the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is a Germany-based health care company focused on the treatment of chronic kidney failure. The company provides dialysis care for patients with end-stage renal disease through a network of outpatient dialysis clinics and other health care facilities.

In addition to operating dialysis centers, Fresenius Medical Care develops and supplies products used in dialysis treatment. Its portfolio includes hemodialysis machines, dialyzers, dialysis solutions, bloodlines, and related medical devices and services.